Dr. Gallardo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
959 Sunland Park Dr
Suite B
El Paso, TX 79922Phone+1 915-542-0279Fax+1 915-542-0156
Summary
- Dr. Mark Gallardo is an ophthalmologist in El Paso, TC and Las Cruces, NM and is affiliated with multiple hospitals in the area, including Las Palmas Medical Center, University Medical Center of El Paso, and MountainView Regional Medical Center. He received his medical degree from Texas Tech University Health Sciences Center School of Medicine, residency at 🇺🇳 versify of Texas Health Sciences center in San Anontio and a glaucoma fellowship at the prestigious University of Texas Southwestern in Dallas. He has been in practice 16 years. He specializes is the only fellowship trained glaucoma specialist in the region and has been designated a Center of Excellence in micro invasive glaucoma surgery—one of two in the US. He also specializes in advanced cataract and other anterior segment procedures. Dr. Gallardo os a principle investigator for a multitude of clinical trials, providing the latest technology to his patients.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Glaucoma, 2005 - 2006
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Ophthalmology, 2002 - 2005
- Texas Tech University HSC El PasoInternship, Transitional Year, 2001 - 2002
- Texas Tech University Health Sciences Center School of MedicineClass of 2001
Certifications & Licensure
- TX State Medical License 2005 - 2026
- NM State Medical License 2012 - 2025
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical System Start of enrollment: 2020 Aug 21
- Hydrus® Microstent New Enrollment Post-Approval Study Start of enrollment: 2020 Aug 25
- Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma Start of enrollment: 2019 Feb 22
Roles: Contact
Publications & Presentations
PubMed
- Consistency in Standalone Canaloplasty Outcomes Using the iTrack Microcatheter.Mahmoud A Khaimi, Norbert Koerber, Simon Ondrejka, Mark J Gallardo
Clinical Ophthalmology. 2024-01-01 - Incidence of Postsurgical Intraocular Inflammation 6 Months After Implantation with a Multifocal Intraocular Lens.James Paauw, Michael B Caplan, Mark Gallardo, Kristi Rushin, Jeffrey D Horn
Clinical Ophthalmology. 2024-01-01 - 3 citationsEfficacy and Safety of Pairing iStent Inject Trabecular Micro-Bypass and iAccess Precision Blade Goniotomy in Patients with Open-Angle Glaucoma.Mark J Gallardo, Matthew Porter
Ophthalmology and Therapy. 2023-08-01
Press Mentions
- Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual MeetingJuly 22nd, 2021
- Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive SurgeryMay 1st, 2019
- Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive SurgeryApril 11th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: